# Avivomed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avivomed

- Industry: Healthcare
- Headquarters: Minneapolis, US
- Website: http://www.avivomed.com
- Total disclosed funding: $32M
- Latest round: Series A (Dec 1, 2021)
- Investors on record: 1

## About

Based in Minneapolis, US, and founded in 2020, Avivomed, Inc. is a healthcare company, that focuses on the development of neuromodulation technology platforms to treat patients suffering from chronic conditions. In December 2021, the firm raised USD 32 million in series A funding, and it is being led by its co-founder and CEO, Steve Masson. The company also operates in Ireland.

Avivomed, Inc.’s team of engineers and product developers engages in the research and development of implantable medical devices that are used to alter or regulate nerve activity by delivering electrical or pharmaceutical substances directly to the target location. The company's novel neuromodulation therapy is designed to address unmet therapeutic requirements that affect huge patient populations.

The company plans to deploy the funds to accelerate its product development and commercialization operations.

## Funding rounds

- Series A, Dec 1, 2021, $32M — Treo Ventures

## Investors

- Treo Ventures (https://capitalatlas.ai/funds/treo-ventures) — Series A